| Pays | Titre |
|---|
 | Greuter T et al Therapeutic Drug Monitoring to guide clinical decision making in Inflammatory Bowel Disease patients with loss of response to ANTI-TNFs: a delphi technique-based consensus Digestion. 2019 Aug 28:1-9 |
| Ooi CJ et al. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia Intest Res,May 31, 2019 |
| Papamichael K. et al. Appropriate Therapeutic drug Monitoring of Biologics Agents for patients with inflammatory Bowel diseases Clinical Gastroenterology and Hepatology, 24 March 2019 |
| Khan A et al. New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease N Z Med J. 2019 Mar 8;132(1491):46-62 |
| Turner D et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline J Pediatr Gastroenterol Nutr. 2018 May 30. |
| Turner D et al. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline J Pediatr Gastroenterol Nutr. 2018 May 30. |
| Maaser C. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications Journal of Crohn’s and Colitis, 2018, 1–32 |
| Lichtenstein G. R et al. Clinical Guideline: Management of Crohn’s Disease in Adults Am J Gastroenterol 2018; 113:481–517 |
| Mitrev N. et al. Consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. |
| Vande Casteele N. et al. Therapeutic Drug Monitoring in Inflammatory Bowel Disease Gastroenterology. 2017;153(3):835-857.e6. |
| Peyrin-Biroulet L et al. French National Consensus Clinical Guidelines for the Management of CD Dig Liver Dis. 2017; 49(4):368-377 |
| Magro F et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Ulcerative Colitis J Crohns Colitis. 2017; 11(6):649-670. |
| Harbord M et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease J Crohns Colitis. 2017; 11(1):3-25 |
| Peyrin-Biroulet L. et al.French National Consensus Clinical Guidelines for the Management of Ulcerative Colitis Dig Liver Dis. 2016; 48(7):726-33 |
| Diagnostics Guidance [DG22] on Therapeutic monitoring of TNF-alpha Inhibitors in Crohn’s Disease https://www.nice.org.uk/guidance/dg22/chapter/1-Recommendations |
| A Hillary Steinhart et al. Clinical Practice Guidelines for the Medical Management of Non-hospitalized Ulcerative Colitis Gastroenterology. 2015; 148(5):1035-1058.e3. |
| F M Ruemmele et al. Consensus Guidelines of ECCO/ESPGHAN on the Medical Management of Pediatric Crohn’s Disease J Crohns Colitis. 2014;8(10):1179-207. |
